Publications

2024

Cardiovascular Adverse Events Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-analysis.

Clinical therapeutics.46(2):134-145[DOI] 10.1016/j.clinthera.2023.11.014.[PMID] 38102000.

PubMed·Publisher's Site

2024

Differences in clinical presentation and outcomes in pregnancy-associated Takotsubo Syndrome- A scoping review of the literature: Outcomes in pregnancy-associated Takotsubo.

Current problems in cardiology.49(1 Pt C):102175-[DOI] 10.1016/j.cpcardiol.2023.102175.[PMID] 37913927.

PubMed·Publisher's Site

2023

Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient.

Archive of clinical cases.10(2):89-92[DOI] 10.22551/2023.39.1002.10248.[PMID] 37313125.

0 citations·PubMed·Publisher's Site

2023

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology.

Cureus.15(7):e41564-[DOI] 10.7759/cureus.41564.[PMID] 37565123.

1 citations·PubMed·Publisher's Site

2022

Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure.

Journal of cardiopulmonary rehabilitation and prevention.42(1):39-44[DOI] 10.1097/HCR.0000000000000605.[PMID] 34793367.

6 citations·PubMed·Publisher's Site

2022

Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMI.

Minerva cardiology and angiology.70(1):25-31[DOI] 10.23736/S2724-5683.20.05303-7.[PMID] 32657561.

PubMed·Publisher's Site

2022

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.

Scientific reports.12(1):1254-[DOI] 10.1038/s41598-022-05374-w.[PMID] 35075216.

14 citations·PubMed·Publisher's Site

2022

Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy.

Cardio-oncology (London, England).8(1):1-[DOI] 10.1186/s40959-021-00127-6.[PMID] 35042565.

3 citations·PubMed·Publisher's Site

2022

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.

European heart journal. Cardiovascular pharmacotherapy.8(5):503-510[DOI] 10.1093/ehjcvp/pvab075.[PMID] 34617567.

28 citations·PubMed·Publisher's Site

2022

Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.

International journal of cardiology.355():23-27[DOI] 10.1016/j.ijcard.2022.03.010.[PMID] 35276244.

4 citations·PubMed·Publisher's Site

2022

Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure.

The American journal of cardiology.174():61-67[DOI] 10.1016/j.amjcard.2022.03.026.[PMID] 35473780.

1 citations·PubMed·Publisher's Site

2022

Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.

Journal of cardiovascular pharmacology.80(5):672-678[DOI] 10.1097/FJC.0000000000001331.[PMID] 35881895.

PubMed·Publisher's Site

2022

Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction.

Circulation. Heart failure.15(10):e009518-[DOI] 10.1161/CIRCHEARTFAILURE.122.009518.[PMID] 36098058.

12 citations·PubMed·Publisher's Site

2021

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.

PloS one.16(5):e0247357-[DOI] 10.1371/journal.pone.0247357.[PMID] 33956804.

7 citations·PubMed·Publisher's Site

2021

Clinical features and outcomes between African American and Caucasian patients with Takotsubo Syndrome.

Minerva cardiology and angiology.69(6):750-759[DOI] 10.23736/S2724-5683.20.05456-0.[PMID] 33427424.

3 citations·PubMed·Publisher's Site

2021

Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus.

Journal of the American Heart Association.10(8):e018631-[DOI] 10.1161/JAHA.120.018631.[PMID] 33825487.

4 citations·PubMed·Publisher's Site

2021

Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study.

Journal of cardiovascular pharmacology.78(3):407-410[DOI] 10.1097/FJC.0000000000001083.[PMID] 34132690.

PubMed·Publisher's Site

2021

Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience.

Cardio-oncology (London, England).7(1):40-[DOI] 10.1186/s40959-021-00126-7.[PMID] 34847948.

3 citations·PubMed·Publisher's Site

2021

The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics.

The American journal of cardiology.142():143-145[DOI] 10.1016/j.amjcard.2020.12.012.[PMID] 33333073.

3 citations·PubMed·Publisher's Site

2021

Time of eating and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction and obesity.

Nutrition, metabolism, and cardiovascular diseases : NMCD.31(8):2471-2473[DOI] 10.1016/j.numecd.2021.04.018.[PMID] 34112580.

4 citations·PubMed·Publisher's Site

2020

Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.

Journal of cardiovascular pharmacology.76(1):50-52[DOI] 10.1097/FJC.0000000000000847.[PMID] 32398478.

17 citations·PubMed·Publisher's Site

2020

Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors.

The American journal of cardiology.125(6):988-996[DOI] 10.1016/j.amjcard.2019.12.019.[PMID] 31928717.

16 citations·PubMed·Publisher's Site

2020

Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions.

The American journal of cardiology.125(1):76-81[DOI] 10.1016/j.amjcard.2019.09.036.[PMID] 31703805.

10 citations·PubMed·Publisher's Site

2020

Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.

Journal of the American Heart Association.9(5):e014941-[DOI] 10.1161/JAHA.119.014941.[PMID] 32122219.

134 citations·PubMed·Publisher's Site

2020

Peak Oxygen Uptake Recovery Delay After Maximal Exercise in Patients With Heart Failure.

Journal of cardiopulmonary rehabilitation and prevention.40(6):434-437[DOI] 10.1097/HCR.0000000000000502.[PMID] 32332250.

1 citations·PubMed·Publisher's Site

2020

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.

Journal of cardiovascular pharmacology.77(1):49-60[DOI] 10.1097/FJC.0000000000000931.[PMID] 33235030.

59 citations·PubMed·Publisher's Site

2020

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study.

Diabetes/metabolism research and reviews.36(8):e3335-[DOI] 10.1002/dmrr.3335.[PMID] 32415802.

26 citations·PubMed·Publisher's Site

2019

Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).

Journal of cardiovascular pharmacology.74(3):266-269[DOI] 10.1097/FJC.0000000000000706.[PMID] 31356537.

19 citations·PubMed·Publisher's Site

2019

Association of Anti-Mullerian Hormone with C-Reactive Protein in Men.

Scientific reports.9(1):13081-[DOI] 10.1038/s41598-019-49596-x.[PMID] 31511566.

5 citations·PubMed·Publisher's Site

2019

IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.

American journal of respiratory and critical care medicine.199(3):381-384[DOI] 10.1164/rccm.201809-1631LE.[PMID] 30418047.

61 citations·PubMed·Publisher's Site

2019

Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.

Journal of cardiovascular pharmacology.74(6):528-534[DOI] 10.1097/FJC.0000000000000740.[PMID] 31809403.

1 citations·PubMed·Publisher's Site

2019

Potential role for interleukin-1 in the cardio-renal syndrome.

European journal of heart failure.21(3):385-386[DOI] 10.1002/ejhf.1403.[PMID] 30666820.

8 citations·PubMed·Publisher's Site

2019

Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.

The American journal of cardiology.123(3):466-473[DOI] 10.1016/j.amjcard.2018.10.027.[PMID] 30502049.

33 citations·PubMed·Publisher's Site

2019

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.

JACC. Basic to translational science.4(4):563-565[DOI] 10.1016/j.jacbts.2019.04.001.[PMID] 31468011.

24 citations·PubMed·Publisher's Site

2018

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.

Frontiers in cardiovascular medicine.5():178-[DOI] 10.3389/fcvm.2018.00178.[PMID] 30619885.

18 citations·PubMed·Publisher's Site

2018

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.

Journal of cardiovascular pharmacology.72(1):68-70[DOI] 10.1097/FJC.0000000000000591.[PMID] 29738374.

17 citations·PubMed·Publisher's Site

2018

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.

Diabetes, obesity & metabolism.20(8):2014-2018[DOI] 10.1111/dom.13309.[PMID] 29603546.

24 citations·PubMed·Publisher's Site

2018

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Circulation. Heart failure.11(8):e005036-[DOI] 10.1161/CIRCHEARTFAILURE.118.005036.[PMID] 30354558.

118 citations·PubMed·Publisher's Site

2018

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.

ESC heart failure.5(2):372-378[DOI] 10.1002/ehf2.12235.[PMID] 29345112.

35 citations·PubMed·Publisher's Site

2018

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.

Clinical cardiology.41(8):1004-1008[DOI] 10.1002/clc.22988.[PMID] 30033595.

37 citations·PubMed·Publisher's Site

2018

Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.

The American journal of cardiology.122(8):1366-1370[DOI] 10.1016/j.amjcard.2018.07.002.[PMID] 30244844.

47 citations·PubMed·Publisher's Site

2017

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.

Drug design, development and therapy.11():2121-2129[DOI] 10.2147/DDDT.S114091.[PMID] 28744103.

8 citations·PubMed·Publisher's Site

2017

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction.

JACC. Basic to translational science.2(5):513-525[DOI] 10.1016/j.jacbts.2017.06.009.[PMID] 30062167.

49 citations·PubMed·Publisher's Site

2017

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).

Circulation. Heart failure.10(11):-[DOI] 10.1161/CIRCHEARTFAILURE.117.004373.[PMID] 29141858.

158 citations·PubMed·Publisher's Site

2017

Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.

The American journal of cardiology.120(10):1854-1857[DOI] 10.1016/j.amjcard.2017.07.099.[PMID] 28867128.

8 citations·PubMed·Publisher's Site

Show More